|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26 JPY | +4.00% |
|
+4.00% | -42.22% |
Solasia Pharma K.K. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was JPY 220 million. Net loss was JPY 241 million.
Basic loss per share from continuing operations was JPY 1.44. Diluted loss per share from continuing operations was JPY 1.44.
| 1st Jan change | Capi. | |
|---|---|---|
| -42.22% | 30.07M | |
| -4.64% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
SOLASIA PHARMA K.K. 
